104 related articles for article (PubMed ID: 17144545)
1. [Detection of residual tumor cells in the bone marrow of children with B-linear acute lymphoblastic leukemia by flow cytofluorometry].
Belevtsev MB; Savitskiĭ VP; Savva NN; Petina OV; Migal' NV; Aleĭnikova OV
Klin Lab Diagn; 2006 Oct; (10):42-6. PubMed ID: 17144545
[No Abstract] [Full Text] [Related]
2. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment.
Yamada M; Wasserman R; Lange B; Reichard BA; Womer RB; Rovera G
N Engl J Med; 1990 Aug; 323(7):448-55. PubMed ID: 2095753
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of marrow cells from children with standard risk-acute lymphoblastic leukemia at the end of therapy into NOD/SCID mice for detecting residual leukemic cells with in vivo growth potential.
Ramírez M; Díaz MA; Madero L; Bueren JA
Leuk Res; 2003 Dec; 27(12):1153-7. PubMed ID: 12921954
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B-cell leukemia.
Magrath IT; Ziegler JL
Leuk Res; 1980; 4(1):33-59. PubMed ID: 6968008
[No Abstract] [Full Text] [Related]
5. Bone marrow involvement in Burkitt's tumour.
Wright DH; Pike PA
Br J Haematol; 1968 Oct; 15(4):409-16. PubMed ID: 5681026
[No Abstract] [Full Text] [Related]
6. Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
Uckun FM; Gaynon PS; Stram DO; Sensel MG; Sarquis MB; Lazarus KH; Willoughby M
Clin Cancer Res; 1999 Sep; 5(9):2415-20. PubMed ID: 10499612
[TBL] [Abstract][Full Text] [Related]
7. Posttherapy surveillance of B-cell precursor acute lymphoblastic leukemia. Value of polymerase chain reaction and limitations of flow cytometry.
Kallakury BV; Hartmann DP; Cossman J; Gootenberg JE; Bagg A
Am J Clin Pathol; 1999 Jun; 111(6):759-66. PubMed ID: 10361511
[TBL] [Abstract][Full Text] [Related]
8. Major impact of an early bone marrow checkpoint (day 21) for minimal residual disease in flow cytometry in childhood acute lymphoblastic leukemia.
Eveillard M; Robillard N; Arnoux I; Garand R; Rialland F; Thomas C; Strullu M; Michel G; Béné MC; Fossat C; Loosveld M
Hematol Oncol; 2017 Jun; 35(2):237-243. PubMed ID: 26449287
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of persistent peripheral blood and bone marrow lymphoblasts on day 15 of therapy in childhood acute lymphoblastic leukemia as detected by flow cytometry.
Jaworska-Posadzy A; Styczynski J; Kubicka M; Debski R; Rafinska-Kurylo B; Kolodziej B; Pogorzala M; Wysocki M
Anticancer Res; 2011 Apr; 31(4):1453-7. PubMed ID: 21508402
[TBL] [Abstract][Full Text] [Related]
10. Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia.
Krampera M; Perbellini O; Vincenzi C; Zampieri F; Pasini A; Scupoli MT; Guarini A; De Propris MS; Coustan-Smith E; Campana D; Foà R; Pizzolo G
Haematologica; 2006 Aug; 91(8):1109-12. PubMed ID: 16885052
[TBL] [Abstract][Full Text] [Related]
11. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
[TBL] [Abstract][Full Text] [Related]
12. Burkitt leukemia with immature B-cell phenotype mimicking acute lymphoblastic leukemia.
Raastad K; Huang Q
Blood; 2021 Feb; 137(5):718. PubMed ID: 33538805
[No Abstract] [Full Text] [Related]
13. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
[TBL] [Abstract][Full Text] [Related]
14. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors.
Farahat N; Lens D; Zomas A; Morilla R; Matutes E; Catovsky D
Br J Haematol; 1995 Nov; 91(3):640-6. PubMed ID: 8555067
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of BCL-2 can distinguish small numbers of acute lymphoblastic leukaemia cells from B-cell precursors.
Hartung L; Bahler DW
Br J Haematol; 2004 Oct; 127(1):50-8. PubMed ID: 15384977
[TBL] [Abstract][Full Text] [Related]
16. [Characterization of CD10 expression and its significance in minimal residual disease detection in childhood B-acute lymphoblastic leukemia].
Zhao HJ; Xu C; Chen J; Wu ZH; Xue HL; Tang JY; Pan C; Chen J; Li L; Gu LJ; Shen LS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Aug; 11(4):350-4. PubMed ID: 12962560
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase detection by three-color flow cytometry in acute lymphoblastic leukemia.
García Vela JA; Delgado I; Oña F
Am J Clin Pathol; 1999 Jul; 112(1):122-4. PubMed ID: 10396294
[No Abstract] [Full Text] [Related]
18. PCR assessment of bone marrow status in 'isolated' extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia.
Goulden N; Langlands K; Steward C; Katz F; Potter M; Chessells J; Oakhill A
Br J Haematol; 1994 Jun; 87(2):282-5. PubMed ID: 7947268
[TBL] [Abstract][Full Text] [Related]
19. Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features.
Rimsza LM; Larson RS; Winter SS; Foucar K; Chong YY; Garner KW; Leith CP
Am J Clin Pathol; 2000 Jul; 114(1):66-75. PubMed ID: 10884801
[TBL] [Abstract][Full Text] [Related]
20. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.
Winick NJ; McKenna RW; Shuster JJ; Schneider NR; Borowitz MJ; Bowman WP; Jacaruso D; Kamen BA; Buchanan GR
J Clin Oncol; 1993 Feb; 11(2):209-17. PubMed ID: 8426196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
